RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

193 hedge funds and large institutions have $1.36B invested in Revance Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 25 closing their positions.

Holders
193
Holders Change
+11
Holders Change %
+6.04%
% of All Funds
3.11%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
38
Increased
79
Reduced
52
Closed
25
Calls
$156M
Puts
$57.2M
Net Calls
+$98.4M
Net Calls Change
-$49.9M
Name Market Value Shares Shares
Change
Shares
Change %
HM
201
HealthCor Management
New York
-64,590 Closed
EGI
202
EAM Global Investors
California
-63,279 Closed
PP
203
PDT Partners
New York
-45,800 Closed
Marshall Wace
204
Marshall Wace
United Kingdom
-41,253 Closed
GC
205
Guggenheim Capital
Illinois
-32,735 Closed
BFM
206
Boothbay Fund Management
New York
-20,619 Closed
ACM
207
AlphaCrest Capital Management
New York
-17,642 Closed
HI
208
HBK Investments
Texas
-15,000 Closed
WG
209
Winton Group
United Kingdom
-10,150 Closed
Teacher Retirement System of Texas
210
Teacher Retirement System of Texas
Texas
-9,907 Closed
EWA
211
Exencial Wealth Advisors
Oklahoma
-9,045 Closed
KWM
212
Kingsview Wealth Management
Oregon
-8,982 Closed
ACM
213
Aquatic Capital Management
Illinois
-3,300 Closed
MSFP
214
Mark Sheptoff Financial Planning
Connecticut
-2,000 Closed
Macquarie Group
215
Macquarie Group
Australia
-539 Closed
EW
216
Evoke Wealth
California
-300 Closed
C
217
Covestor
United Kingdom
$0 8 -3 -27%
HT
218
HAP Trading
New York
AC
219
Antara Capital
New York
Parallax Volatility Advisers
220
Parallax Volatility Advisers
California
TLP
221
Tri Locum Partners
New York
CFGS
222
Concourse Financial Group Securities
Alabama
CAL
223
Capital Advisors Ltd
Ohio
$0 760 +760 New